Orizon LLC and Orthopaedic Research and Education Foundation Form Partnership to Advance Innovation in Patient Care

ATLANTA, GA / ACCESSWIRE / May 21, 2024 / Orizon LLC and the Orthopaedic Research and Education Foundation (OREF) have announced the creation of the Orizon Fund. This healthcare venture fund aims to accelerate the commercialization of orthopaedic healthcare solutions derived from OREF-funded research. The fund will offer financial and operational support to new companies, aiding in general management, product development, regulatory practices, and healthcare reimbursement guidelines.

OREF will identify grant recipients with promising healthcare research and invite them for evaluation. Orizon LLC will assist these researchers in developing business and product plans, ensuring commercial viability. According to Joshua J. Jacobs, MD, OREF President, this partnership will help OREF improve patient care by bringing innovative solutions to the market efficiently.

Orizon LLC will conduct a competitive selection process to choose the most innovative solutions from OREF grant recipients. Each selected solution will form a standalone subsidiary under Orizon LLC, which will provide resources for product development. The selection will focus on innovations that address unmet clinical needs and stand out in the marketplace.

Jagi Gill, Managing Partner of Orizon, expressed excitement about the partnership, highlighting the opportunity to support early-stage investigators and advance medical innovations that improve patient outcomes. The Orizon Fund represents a strategic effort to combine financial and operational resources, ensuring successful commercialization of breakthrough medical technologies.